Market News
Smart Trading. Simplified.
Stock Market Whiz Kid Works 1 Hour a Day. Makes Millions.
He was living with his parents. Two years later he had $5 million to play with - all because of this 1 EXTRA INCOME strategy.
To see how he did it click here.
Sponsored
SpaceX Vs Virgin Galactic Stock: Which Is Best?
The idea of billionaires trying to send us into space sounds like the plot of a Dr. Who or Black Mirror episode. But it’s the reality of the 2020s and one that’s more than 20 years in the making. Jeff Bezos and Richard Branson each believe they can take investors and customers to the moon. […]
Shares Set to Triple as Drilling Resumes at Massive Palladium Find
Palladium is stealing headlines as the market's hottest in-demand precious metal, and investors aren't wasting any time getting in-position for triple and quadruple-digit gains by buying-up the top miners. The largest gains are set to come from the small-cap developers like the one here: Drilling a massive North American palladium discovery and trading under-the-radar below $0.75 per share.
Sponsored
Oil Stocks That Will Go Up
Oil prices fell to a historic low below zero at the onset of the pandemic. The economic shutdown created massive supply chain issues through the industry and dropped gas pumps to the lowest prices many saw in their lifetimes. As the economy recovers, oil is being used more. This is driving oil prices up, and […]
My #1 Small Cap Stock for March
Ex-Wall Street CEO Dylan Jovine has racked up big gains in small caps stocks. He's had three picks jump 100%, 111% and 171% just in the past 90 days!
Sponsored
Is Ark Innovation ETF A Buy?
Is Ark Innovation ETF A Buy? Dozens of industries are stuck in a rut, doing business with the same tools and techniques they have relied on for decades. The digital revolution – and the integration of Artificial Intelligence (AI), Virtual Reality (VR), Augmented Reality (AR), and Machine Learning – are challenging the status quo. Innovative […]
Small Biotech Could Soar 1,000%
There's no sector poised to deliver bigger gains in 2021 than small-cap biotech stocks.
In the past year alone...
Novavax Inc jumped from $6.26 to $270.51, a gain of 3,396%.
Aclaris Therapts jumped from $0.70 to $24.28 an increase of 1,583%.
Vaxart Inc rocketed from $0.97 to $14.94, a 1,083% jump.
Here's the next biotech we think could soar 1,000% >>>
Sponsored
Best Electric Vehicle Stocks To Buy
Best Electric Vehicle Stocks To Buy: Climate change is one of the most pressing issues of the 21st century, and both public and private sector leaders are focused on solutions. Electric vehicles top the list as an effective, achievable option for reducing emissions worldwide. Companies that were once exiled to the outskirts of the industry […]
Small Biotech Could Soar 1,000%
On December 5, 2020, a small Cambridge biotech shocked the world when they could "Find & Replace" the genes that cause the disease anemia. Investor's Business Daily estimates the total market at $75 billion. But right now, its stock is just a tiny fraction of that size.
Here's the next biotech we think could soar 1,000% >>>
Sponsored
Is Alibaba Or Amazon Bigger?
Amazon (AMZN) and Alibaba (BABA) are market giants. Each dominates in their respective market territory, and they operate in the same eCommerce industry space. But which is bigger? And from an investment perspective, which stock represents the best value? How Is Alibaba Different To Amazon? Both Amazon and Alibaba were created during the 1990s, with […]
Small Biotech Firm Stuns World
On November 16, 2016 a small biotech used a radical new treatment to restore blindness in mice. CBS News called this breakthrough "the most consequential discovery in biomedicine this century."
Investors who get in early are set to earn 46,751% returns.
Sponsored
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment